Dr Matthew Watson matthew.s.watson@durham.ac.uk
Post Doctoral Research Associate
Dr Matthew Watson matthew.s.watson@durham.ac.uk
Post Doctoral Research Associate
Pinkie Chambers
Luke Steventon
James Harmsworth King
Angelo Ercia
Heather Shaw
Dr Noura Al Moubayed noura.al-moubayed@durham.ac.uk
Associate Professor
Objectives: Routine monitoring of renal and hepatic function during chemotherapy ensures that treatment-related organ damage has not occurred and clearance of subsequent treatment is not hindered; however, frequency and timing are not optimal. Model bias and data heterogeneity concerns have hampered the ability of machine learning (ML) to be deployed into clinical practice. This study aims to develop models that could support individualised decisions on the timing of renal and hepatic monitoring while exploring the effect of data shift on model performance. Methods and analysis: We used retrospective data from three UK hospitals to develop and validate ML models predicting unacceptable rises in creatinine/bilirubin post cycle 3 for patients undergoing treatment for the following cancers: breast, colorectal, lung, ovarian and diffuse large B-cell lymphoma. Results: We extracted 3614 patients with no missing blood test data across cycles 1–6 of chemotherapy treatment. We improved on previous work by including predictions post cycle 3. Optimised for sensitivity, we achieve F2 scores of 0.7773 (bilirubin) and 0.6893 (creatinine) on unseen data. Performance is consistent on tumour types unseen during training (F2 bilirubin: 0.7423, F2 creatinine: 0.6820). Conclusion: Our technique highlights the effectiveness of ML in clinical settings, demonstrating the potential to improve the delivery of care. Notably, our ML models can generalise to unseen tumour types. We propose gold-standard bias mitigation steps for ML models: evaluation on multisite data, thorough patient population analysis, and both formalised bias measures and model performance comparisons on patient subgroups. We demonstrate that data aggregation techniques have unintended consequences on model bias.
Watson, M., Chambers, P., Steventon, L., Harmsworth King, J., Ercia, A., Shaw, H., & Al Moubayed, N. (2024). From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers. BMJ Oncology, 3(1), Article e000430. https://doi.org/10.1136/bmjonc-2024-000430
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 7, 2024 |
Online Publication Date | Nov 2, 2024 |
Publication Date | 2024-11 |
Deposit Date | Nov 6, 2024 |
Publicly Available Date | Nov 8, 2024 |
Journal | BMJ Oncology |
Print ISSN | 2752-7948 |
Electronic ISSN | 2752-7948 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 3 |
Issue | 1 |
Article Number | e000430 |
DOI | https://doi.org/10.1136/bmjonc-2024-000430 |
Public URL | https://durham-repository.worktribe.com/output/3083397 |
Published Journal Article
(1.2 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Agree to Disagree: When Deep Learning Models With Identical Architectures Produce Distinct Explanations
(2022)
Presentation / Conference Contribution
Attack-agnostic Adversarial Detection on Medical Data Using Explainable Machine Learning
(2021)
Presentation / Conference Contribution
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search